UK says Sanofi, Merck recall some typhoid vaccine batches
LONDON (Reuters) - Sanofi Pasteur MSD, the vaccine joint venture of Sanofi and Merck & Co, has recalled some batches of its typhoid vaccine because of concerns about effectiveness, Britain's drug regulator said on Monday.
The decision to recall 16 batches of Typhim Vi follows filling problems in the manufacturing process, according to the Medicines and Healthcare Products Regulatory Agency.
"There are no concerns over the safety of this vaccine but the recall has taken place because the vaccine may not be as effective as it should be," agency official Ian Holloway said.
(Reporting by Ben Hirschler; Editing by David Cowell)
- White House reverses, says Obama met uncle and lived with him during law school
- South Africa mourns Mandela, will bury him on December 15 |
- Flights delayed as air pollution hits record in Shanghai
- RPT-UPDATE 1-Ford leans on global Mustang to burnish overseas image
- Struggling Sears to spin off Lands' End clothing label
Nelson Mandela: 1918 - 2013
Reuters looks at the life and times of Nelson Mandela, an icon of peace and reconciliation who came to embody the struggle for justice around the world. Video